Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes”
CNS Drugs · 2026-06 · 40 (6) · 835-836
DOI: 10.1007/s40263-026-01288-7 ↗Kurz gefasst
Leserbrief in der Zeitschrift CNS Drugs, online erschienen am 14.05.2026. Verfasst von Per Damkier. Beteiligte Einrichtung: Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark. pdamkier@health.sdu.dk. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark. pdamkier@health.sdu.dk.
Zitieren
APA
Damkier, P. (2026). Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes”. CNS Drugs, 40(6), 835-836. https://doi.org/10.1007/s40263-026-01288-7
Vancouver
Damkier P. Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes”. CNS Drugs. 2026;40(6):835-836. doi:10.1007/s40263-026-01288-7
BibTeX
@article{Damkier2026,
author = {Damkier, Per},
title = {Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes”},
journal = {CNS Drugs},
year = {2026},
volume = {40},
number = {6},
pages = {835--836},
doi = {10.1007/s40263-026-01288-7}
}
EUVIMED